By Counterforce Health Team in Besponsa (inotuzumab ozogamicin) —

How to Get Besponsa Covered by UnitedHealthcare in New York: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Besponsa Covered by UnitedHealthcare in New York

Besponsa (inotuzumab ozogamicin) requires prior authorization from UnitedHealthcare for all commercial and Medicare plans. Your oncologist must document CD22-positive B-cell ALL, failed first-line therapy, and hepatic monitoring plans. If denied, you have 180 days for internal appeals and 4 months for New York State external review. First step today: Have your provider submit the PA through the UnitedHealthcare Provider Portal with complete clinical documentation.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Timeline and Urgency
  4. Medical Necessity Criteria
  5. Cost and Copay Assistance
  6. Denials and Appeals
  7. Renewals and Reauthorization
  8. Specialty Pharmacy Requirements
  9. Troubleshooting Common Issues
  10. Frequently Asked Questions

Coverage Basics

Is Besponsa Covered by UnitedHealthcare?

Yes, Besponsa appears on select 2025 UnitedHealthcare and OptumRx formularies, but coverage requires prior authorization and adherence to strict medical necessity criteria. The drug is typically placed on higher formulary tiers due to its specialty status and high cost (approximately $8,700 per 0.9-mg vial).

Which UnitedHealthcare Plans Cover Besponsa?

  • Commercial plans (employer-sponsored)
  • Medicare Advantage plans
  • Individual marketplace plans in New York
  • Coverage varies by specific plan design and formulary tier
Note: Medicaid managed care plans through UnitedHealthcare may have different coverage rules. Check your specific plan documents or call member services.

Prior Authorization Process

Who Submits the Prior Authorization?

Your oncologist or hematologist must submit the prior authorization request. Patients cannot submit PA requests directly to UnitedHealthcare.

Step-by-Step: Fastest Path to Approval

  1. Provider logs into UnitedHealthcare Provider Portal
    • Use the Prior Authorization and Notification tool
    • Timeline: Immediate submission capability
  2. Complete clinical documentation (see Medical Necessity Criteria below)
    • Include diagnosis codes, prior therapy records, monitoring plan
    • Timeline: 1-2 business days to gather records
  3. Submit PA request with supporting documents
    • Upload all required clinical notes and lab results
    • Timeline: Same day submission
  4. UnitedHealthcare reviews request
    • Standard review: 5-15 business days
    • Expedited review: 72 hours (if urgent criteria met)
  5. Receive determination
    • Approval: Prescription can be filled
    • Denial: Internal appeal rights begin
  6. If approved, coordinate with specialty pharmacy
    • OptumRx Specialty or network specialty pharmacy
    • Timeline: 1-3 days for first shipment
  7. Begin treatment with required monitoring
    • Follow hepatic function monitoring protocol
    • Document response for potential reauthorization

Timeline and Urgency

Standard Review Timeline

  • Initial PA decision: 5-15 business days
  • Internal appeal: 30 days for standard, 72 hours for expedited
  • External appeal (New York): 30 days for standard, 72 hours for expedited

When to Request Expedited Review

Request expedited review if waiting for standard processing would:

  • Seriously jeopardize your health
  • Compromise your ability to regain maximum function
  • Subject you to severe pain that cannot be adequately managed

Your physician must provide clinical justification for expedited processing.

Medical Necessity Criteria

Required Documentation for Approval

Diagnosis Requirements:

  • Confirmed CD22-positive B-cell precursor acute lymphoblastic leukemia
  • Pathology reports with immunophenotyping results
  • Appropriate ICD-10 diagnosis codes

Prior Therapy Documentation:

  • Detailed records of first-line chemotherapy regimen
  • Evidence of treatment failure, intolerance, or contraindication
  • Specific drugs, doses, durations, and clinical responses
  • Step therapy compliance or exception justification

Safety Monitoring Plan:

  • Baseline liver function tests (ALT, AST, bilirubin, alkaline phosphatase)
  • Hepatitis screening results
  • Plan for ongoing hepatic monitoring during treatment
  • VOD/SOS risk assessment and mitigation strategy
Clinician Corner: Medical necessity letters should reference current NCCN guidelines for relapsed/refractory ALL and include specific citations supporting Besponsa use in your patient's clinical scenario.

Cost and Copay Assistance

Understanding Your Costs

Typical Cost Structure:

  • Tier 4 or 5 specialty drug: 25-50% coinsurance common
  • Annual out-of-pocket maximum applies
  • Deductible may apply before coverage begins

Available Assistance Programs

  1. Pfizer Patient Assistance Program
    • Eligibility based on income and insurance status
    • May reduce copays to $10-$25 per month for eligible patients
  2. UnitedHealthcare OptumRx Programs
    • Check patient portal for available assistance
    • Some plans offer specialty drug copay caps
  3. Foundation Grants
    • Leukemia & Lymphoma Society
    • Patient Advocate Foundation
    • CancerCare Co-Payment Assistance Foundation

Denials and Appeals

Common Denial Reasons and Solutions

Denial Reason How to Overturn
Step therapy not met Document prior therapy failures with specific clinical details
CD22 status not confirmed Submit immunophenotyping results showing CD22-positive disease
Hepatic risk not addressed Provide comprehensive VOD monitoring and mitigation plan
Off-label use Submit evidence supporting on-label indication for relapsed/refractory B-ALL

UnitedHealthcare Internal Appeals Process

Level 1 Internal Appeal:

  • Deadline: 180 days from denial date
  • Timeline: 30 days for decision (72 hours if expedited)
  • How to file: Online portal, phone, or written request

Level 2 Internal Appeal:

  • Available for some plan types
  • Same deadlines and timelines as Level 1

New York State External Appeal Process

If UnitedHealthcare upholds the denial after internal appeals, you can request an external review through the New York State Department of Financial Services.

Key Requirements:

  • Deadline: 4 months from final internal denial
  • Cost: $25 filing fee (waived for financial hardship)
  • Timeline: 30 days for standard, 72 hours for expedited
  • Decision: Binding on UnitedHealthcare

How to File External Appeal:

  1. Download form from NY DFS website
  2. Complete application with supporting documentation
  3. Submit to: NY State Department of Financial Services, 99 Washington Avenue, Box 177, Albany, NY 12210
  4. Or fax to: (800) 332-2729
Tip: Community Health Advocates offers free assistance with appeals at 888-614-5400.

Renewals and Reauthorization

When Reauthorization is Required

  • Treatment response assessments: Typically every 2-3 cycles
  • Annual plan renewals: January 1st for most plans
  • Dosing or regimen changes: Any modifications require new PA
  • Provider changes: New oncologist may need to resubmit

Documentation for Renewal

  • Current disease status and treatment response
  • Ongoing monitoring results (liver function, blood counts)
  • Continued medical necessity justification
  • Updated treatment plan and goals

Specialty Pharmacy Requirements

Why Besponsa Requires Specialty Pharmacy

Besponsa must be dispensed through a specialty pharmacy due to:

  • Complex handling and storage requirements
  • Need for specialized patient counseling
  • Coordination with infusion centers
  • Enhanced safety monitoring

OptumRx Specialty Pharmacy Process

  1. Automatic transfer from retail pharmacy after PA approval
  2. Patient outreach for coordination and counseling
  3. Delivery coordination with infusion site
  4. Ongoing support throughout treatment

Troubleshooting Common Issues

Portal and System Issues

Provider Portal Down:

  • Call Provider Services: 1-866-842-3278
  • Fax PA requests to number provided in portal
  • Submit via phone if urgent

Missing Forms or Documents:

  • Check UnitedHealthcare provider resources
  • Contact member services for current forms
  • Verify with Counterforce Health for assistance with complex appeals

Communication Problems

Delayed Responses:

  • Follow up after 10 business days for standard PA
  • Request expedited review if clinically appropriate
  • Escalate to member advocate if needed

Frequently Asked Questions

Q: How long does UnitedHealthcare prior authorization take for Besponsa? A: Standard review takes 5-15 business days. Expedited review (when medically necessary) takes up to 72 hours.

Q: What if Besponsa is not on my plan's formulary? A: Request a formulary exception with your PA submission. Provide clinical justification for why covered alternatives are inappropriate.

Q: Can I appeal if my doctor recommends Besponsa but UnitedHealthcare prefers a different drug? A: Yes. Document why step therapy alternatives failed or are contraindicated, and reference clinical guidelines supporting Besponsa use.

Q: Does step therapy apply if I've already failed treatments outside New York? A: Prior therapy failures from any location should count toward step therapy requirements. Ensure all treatment records are submitted.

Q: What happens if I need Besponsa urgently? A: Request expedited PA review with clinical justification. If denied, file expedited internal and external appeals simultaneously.

Q: How do I check my prior authorization status? A: Log into your UnitedHealthcare member portal or call member services. Your provider can also check status through the provider portal.

Q: What if UnitedHealthcare requires peer-to-peer review? A: Your oncologist will need to speak directly with a UnitedHealthcare medical director. This is typically scheduled within 1-2 business days of the request.

Q: Are there alternatives if all appeals fail? A: Consider clinical trials, manufacturer compassionate use programs, or patient assistance programs. Counterforce Health specializes in turning insurance denials into successful appeals with evidence-backed documentation.

From Our Advocates

"We've seen many Besponsa approvals succeed when providers include detailed hepatic monitoring protocols and cite specific NCCN guideline sections supporting use in relapsed B-ALL. The key is demonstrating both medical necessity and safety oversight—payers want to see you've addressed the VOD risk proactively."

When navigating complex prior authorizations and appeals, Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Their platform identifies denial reasons and drafts point-by-point rebuttals aligned to each plan's specific requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal procedures may change. Always consult your healthcare provider and insurance plan documents for the most current information specific to your situation. For additional help with insurance appeals in New York, contact Community Health Advocates at 888-614-5400 or the New York State Department of Financial Services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.